CIK: 1444043 - Address: 101 Huntington Avenue, Suite 2101, Boston, MA 02199
8 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

P%ret317-04-4989719
P%wins43714357145046

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/9/19 15:41
8/7/19
AMAGAmag Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsCamber Capital Management LPMATP.m3,0307.870385104,390I
2/25/16 16:37
2/23/16
CSIICardiovascular Systems IncDEHealthMdEqSurgical & Medical InstrumentCamber Capital Management LLCMATP1,8897.55425064,100I-78-78-66-45-42-15-2-331417103203244
1/4/16 16:50
12/30/15
SQNMSequenom IncDEElectrLabEqMeasuring & Controlling DevicCamber Capital Management LLCMATP.m1,0781.622665417,325I-30-56-44-21-121-10-6-16-4-10-43
12/17/15 09:45
12/14/15
SQNMSequenom IncDEElectrLabEqMeasuring & Controlling DevicCamber Capital Management LLCMATP.am6101.301468316,660I-33-59-56-42-18-202213-115-164-18
12/16/15 17:38
12/14/15
SQNMSequenom IncDEElectrLabEqMeasuring & Controlling DevicCamber Capital Management LLCMATP.m6101.301468316,660I-32-60-55-30-17-1577-112-142-19
12/10/15 16:44
12/8/15
SQNMSequenom IncDEElectrLabEqMeasuring & Controlling DevicCamber Capital Management LLCMATP.m1,0271.301792516,192I-45-66-60-38-26-20-25-1-75414-20
10/20/15 14:18
10/19/15
PLXProtalix Biotherapeutics, Inc.FLHealthBioPrdBiological Products, (No DiagCamber Capital Management LLCMATP4,0001.0014,0004313,275I-78-63-52-45-33-25-14-121083-18-13-50
10/8/15 18:46
10/6/15
SQNMSequenom IncDEElectrLabEqMeasuring & Controlling DevicCamber Capital Management LLCMATP.m3,2421.9641,6501215,400I-22-30-49-29-3-176-50-12-21-34-32

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact